Connect Biopharma Holdings Ltd (CNTB): Shareholders' Equity
$41.98M
As of 2025-12-31
$26.86M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.98M | -54.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $92.17M | -9.2% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $101.50M | n/a | 2025-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $41.98M | -54.5% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $6.31M | +25.3% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $2.76M | n/m |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | -$9.02M | n/m |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $7.83M | -76.1% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $224.89M | +82.1% |
| iBio, Inc. (IBIO) | 2026-06-30 | $85.71M | +476.0% |
Compare CNTB, INO, AVTX, SILO side by side · Screen every company in Pharmaceutical Preparations ↗